Liminatus Pharma, Inc. Class A Common Stock
LIMN · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$2,904 | -$4,984 | -$2,928 | $4,370 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $0 | $0 | $0 | $0 |
| Change in WC | -$45 | $1,639 | $1,159 | $1,318 |
| Other Non-Cash | -$158 | $0 | $900 | -$6,904 |
| Operating Cash Flow | -$3,106 | -$3,345 | -$869 | -$1,216 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$189 | -$121 | -$15,128 | -$276,000 |
| Inv. Sales/Matur. | $2,157 | $0 | $279,092 | $0 |
| Other Inv. Act. | $0 | -$698 | $0 | $0 |
| Investing Cash Flow | $1,968 | -$819 | $263,964 | -$276,000 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $2,850 | -$450 | $2,417 | $0 |
| Stock Issued | $0 | $0 | $4,200 | $283,072 |
| Stock Repurch. | -$1,803 | -$10,657 | -$700 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $0 | $10,657 | $0 | -$5,520 |
| Financing Cash Flow | $1,047 | -$450 | $5,917 | $277,552 |
| Forex Effect | $739 | $0 | $0 | $0 |
| Net Chg. in Cash | $648 | -$4,614 | $5,048 | $336 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $156 | $5,048 | $336 | $0 |
| End Cash | $805 | $434 | $5,048 | $336 |
| Free Cash Flow | -$3,106 | -$3,345 | -$869 | -$1,216 |